Epithalon, MOTS-c, and SS-31: Research on Mitochondrial and Longevity Peptides
Share
Introduction: Longevity-Adjacent Research Peptides
Three peptides in the Alpha Biologix research catalog — Epithalon, MOTS-c, and SS-31 (Elamipretide) — represent distinct research approaches to biological aging, mitochondrial function, and cellular longevity mechanisms. This article reviews the published research landscape for each.
Epithalon (Epitalon) — Telomere Research
Overview
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally derived from research on the pineal gland peptide Epithalamin by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology. It is one of the most-studied synthetic peptides in Russian longevity research literature, with publications spanning animal models and limited human studies over more than two decades.
Telomerase Research
The most cited mechanism proposed for Epithalon involves telomerase activation. Telomerase is the enzyme responsible for maintaining telomere length, which shortens with each cell division. Khavinson et al. (2003) reported that Epithalon treatment in somatic cells was associated with increased telomerase activity and restoration of telomere length, proposing this as a cellular mechanism underlying observed anti-aging effects in model systems.
Khavinson V, et al. (2003). Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135(6), 590-592.
Circadian and Pineal Research
Epithalon has also been studied in the context of circadian rhythm regulation and melatonin synthesis. Research in aged rodents proposed that Epithalon administration restored disrupted circadian melatonin secretion patterns toward those of younger animals — a finding of relevance to research on circadian biology and sleep-metabolism interactions.
Cancer Research Models
Multiple publications from Anisimov and colleagues examined Epithalon in rodent spontaneous tumor models, reporting reduced tumor incidence and altered onset timing in several cancer strains. These findings are interpreted cautiously given the complexity of rodent carcinogenesis models, but have driven research interest in Epithalon's potential role in cellular senescence and oncogenesis pathways.
MOTS-c — Mitochondria-Derived Signaling Peptide
Overview
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. It was first characterized by Lee et al. (2015) at the University of Southern California, representing a new class of mitochondria-derived peptides (MDPs) with systemic signaling roles.
Published Research Findings
Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443-454. This landmark paper demonstrated that MOTS-c activates AMPK and the FOXO1 transcription factor, promotes glucose uptake in skeletal muscle, and reduces adiposity in high-fat diet mouse models. Circulating MOTS-c levels were found to decline with age in human plasma samples.
Kim SJ, et al. (2022). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 13(1), 1-17. This study established that MOTS-c is released during exercise, acts as an exercise mimetic in aged muscle tissue, and partially restores muscle function in aged mouse models — with significant implications for aging muscle biology research.
Research Applications
- AMPK pathway activation studies
- Mitochondrial stress response investigations
- Muscle biology and exercise physiology models
- Age-related metabolic decline investigations
SS-31 (Elamipretide) — Mitochondrial Membrane Research
Overview
SS-31, also known as Elamipretide or MTP-131, is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) belonging to the Szeto-Schiller (SS) class of mitochondria-targeted peptides. It preferentially concentrates at the inner mitochondrial membrane by electrostatic interaction with cardiolipin, a phospholipid essential for electron transport chain organization and mitochondrial membrane integrity.
Cardiolipin and Electron Transport Chain Research
Cardiolipin is required for optimal organization of respiratory chain supercomplexes (respirasomes). In aged and diseased cells, cardiolipin undergoes peroxidation, destabilizing supercomplex organization and reducing electron transport efficiency. SS-31 is proposed to protect cardiolipin from peroxidation, preserve supercomplex architecture, and restore electron transport chain efficiency in models of mitochondrial dysfunction.
Szeto HH (2014). First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology, 171(8), 2029-2050.
Published Pre-Clinical and Clinical Research
Pre-clinical studies in aged rodents demonstrated that SS-31 treatment restored mitochondrial morphology, reduced reactive oxygen species production, improved skeletal muscle energetics, and reversed indices of age-related functional decline. Notably:
Siegel MP, et al. (2013). Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice. Aging Cell, 12(5), 763-771. Reported restoration of ATP production rates and improvement in in-vivo muscle performance in aged versus young mice.
In human clinical research, SS-31 (as Elamipretide/MTP-131) has entered clinical trials for conditions associated with mitochondrial dysfunction, including heart failure with preserved ejection fraction and Barth syndrome. Phase 2 data in Barth syndrome (a rare mitochondrial cardiomyopathy) demonstrated improvements in skeletal muscle function and cardiorespiratory endpoints.
Summary: Research Landscape
| Peptide | Primary Mechanism | Key Research Model | Evidence Stage |
|---|---|---|---|
| Epithalon | Telomerase activation | Cellular aging, rodent lifespan | Pre-clinical + limited clinical |
| MOTS-c | AMPK activation, mitochondrial signaling | Metabolic, muscle aging | Pre-clinical + human plasma data |
| SS-31 | Cardiolipin protection, ETC stabilization | Mitochondrial dysfunction, aged muscle | Pre-clinical + Phase 2 clinical |
These Peptides from Alpha Biologix
All three peptides are available as HPLC-verified ≥98% purity research compounds in lyophilized and activated formats. CoAs available at quality@alphabiologix.com.
Manufacturing & Quality
Alpha Biologix manufactures Epithalon, MOTS-c, and SS-31 to pharmaceutical-grade standards. Each compound is HPLC-verified to ≥98% purity, independently tested by third-party laboratories, and supplied with a batch-specific Certificate of Analysis (CoA) available at quality@alphabiologix.com.
All products are for laboratory research use only, not for human consumption.